A strange cause of chylothorax- Dasatinib induced

Abstract

Dasatinib is a potent second-generation tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. Pulmonary side effects like pleural effusion due fluid retention are common. But dasatinib, causing chylothorax is very rarely reported. Exact mechanism along with clinical manifestations is very poorly understood. Here we report 35-year-old man presenting with chylothorax following with dasatinib use.

Keywords

• dasatinib
• chylothorax
• chronic myeloid leukemia